Developmental toxicity risks of medicines included on the WHO’s Essential Medicines List

A collaboration of researchers from the University of Washington School of Medicine and the Washington Center for Epidemiology and Environmental Health have published their findings of a review into the developmental toxicity risks for medicines included on the WHO’s Essential Medicines List. The authors described a large proportion of these medicines had limited data concerning developmental risks, identifying a clear need […]

» Read more

Meta-analysis of malformation risk following maternal ondansetron use in pregnancy

A collaboration between ENTIS researchers from Izmir Katip Celebi University Teratology Information Center, the UK Teratology Information Service and Mothersafe at The Royal Hospital for Women, Sydney, Australia have published a meta-analysis of malformation risks following maternal first-trimester ondansetron use. More information is available here.   Photo by on Unsplash

» Read more

New study of maternal and infant infection risk following use of biologic medication in pregnancy

A small study by a group of researchers from Vancouver has investigated maternal and infant infection risks following the use of a biologic medication in pregnancy. After adjustment, the study findings did not describe any statistically significant increase in serious infection rate for either the exposed mothers or their in utero exposed infants (first year of life). More details can be found […]

» Read more
1 2 3 4